Beta-arrestin/Ral signaling regulates lysophosphatidic acid-mediated migration and invasion of human breast tumor cells
- PMID: 19609003
- DOI: 10.1158/1541-7786.MCR-08-0578
Beta-arrestin/Ral signaling regulates lysophosphatidic acid-mediated migration and invasion of human breast tumor cells
Abstract
The lipid mediator lysophosphatidic acid (LPA) plays a role in cancer progression and signals via specific G protein-coupled receptors, LPA(1-3). LPA has been shown to enhance the metastasis of breast carcinoma cells to bone. However, the mechanisms by which LPA receptors regulate breast cancer cell migration and invasion remain unclear. Breast cancer cell proliferation has been shown to be stimulated by Ral GTPases, a member of the Ras superfamily. Ral activity can be regulated by the multifunctional protein beta-arrestin. We now show that HS578T and MDA-MB-231 breast cancer cells and MDA-MB-435 melanoma cells have higher expression of beta-arrestin 1 mRNA compared with the nontumorigenic mammary MCF-10A cells. Moreover, we found that the mRNA levels of LPA1, LPA2, beta-arrestin 2, and Ral GTPases are elevated in the advanced stages of breast cancer. LPA stimulates the migration and invasion of MDA-MB-231 cells, but not of MCF-10A cells, and this is mediated by pertussis toxin-sensitive G proteins and LPA1. However, ectopic expression of LPA1 in MCF-10A cells caused these cells to acquire an invasive phenotype. Gene knockdown of either beta-arrestin or Ral proteins significantly impaired LPA-stimulated migration and invasion. Thus, our data show a novel role for beta-arrestin/Ral signaling in mediating LPA-induced breast cancer cell migration and invasion, two important processes in metastasis.
Similar articles
-
β-Arrestin2 regulates lysophosphatidic acid-induced human breast tumor cell migration and invasion via Rap1 and IQGAP1.PLoS One. 2013;8(2):e56174. doi: 10.1371/journal.pone.0056174. Epub 2013 Feb 6. PLoS One. 2013. PMID: 23405264 Free PMC article.
-
LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.Am J Physiol Cell Physiol. 2007 May;292(5):C1927-33. doi: 10.1152/ajpcell.00400.2006. Am J Physiol Cell Physiol. 2007. PMID: 17496233
-
A requirement for membrane cholesterol in the beta-arrestin- and clathrin-dependent endocytosis of LPA1 lysophosphatidic acid receptors.J Cell Sci. 2005 Nov 15;118(Pt 22):5291-304. doi: 10.1242/jcs.02634. Epub 2005 Nov 1. J Cell Sci. 2005. PMID: 16263766
-
Roles of LPA receptor signaling in breast cancer.Expert Rev Mol Diagn. 2016 Oct;16(10):1103-1111. doi: 10.1080/14737159.2016.1238763. Epub 2016 Sep 28. Expert Rev Mol Diagn. 2016. PMID: 27644846 Review.
-
Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays.Biol Cell. 2013 Aug;105(8):317-33. doi: 10.1111/boc.201300011. Epub 2013 Jun 3. Biol Cell. 2013. PMID: 23611148 Review.
Cited by
-
LPA(1) -induced migration requires nonmuscle myosin II light chain phosphorylation in breast cancer cells.J Cell Physiol. 2011 Nov;226(11):2881-93. doi: 10.1002/jcp.22631. J Cell Physiol. 2011. PMID: 21302283 Free PMC article.
-
Real-time motion analysis reveals cell directionality as an indicator of breast cancer progression.PLoS One. 2013;8(3):e58859. doi: 10.1371/journal.pone.0058859. Epub 2013 Mar 19. PLoS One. 2013. PMID: 23527039 Free PMC article.
-
KIF14 negatively regulates Rap1a-Radil signaling during breast cancer progression.J Cell Biol. 2012 Dec 10;199(6):951-67. doi: 10.1083/jcb.201206051. Epub 2012 Dec 3. J Cell Biol. 2012. PMID: 23209302 Free PMC article.
-
Positive and Negative Cross-Talk between Lysophosphatidic Acid Receptor 1, Free Fatty Acid Receptor 4, and Epidermal Growth Factor Receptor in Human Prostate Cancer Cells.J Pharmacol Exp Ther. 2016 Oct;359(1):124-33. doi: 10.1124/jpet.116.233379. Epub 2016 Jul 29. J Pharmacol Exp Ther. 2016. PMID: 27474750 Free PMC article.
-
β-arrestin 2 stimulates degradation of HIF-1α and modulates tumor progression of glioblastoma.Cell Death Differ. 2021 Nov;28(11):3092-3104. doi: 10.1038/s41418-021-00802-2. Epub 2021 May 18. Cell Death Differ. 2021. PMID: 34007068 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous